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Abstract
The implications of misdiagnosis can be drastic, especially when the correct diagnosis is treatable.
Pulmonary actinomycosis is one of the complications of infection with actinomyces, an anaerobic grampositive organism that is usually found as a part of the normal flora in the human body infection. It is a
very rare disease and is frequently mistaken with other diagnoses owing to its nonspecific presentation.
In this report, we present a 67-year-old male with a mass like lesion on a CT scan of his chest that was
done due to progressively worsening productive cough, weight loss and fatigue. These symptoms could
have swayed any physician into the diagnosis of possible malignancy. A misdiagnosis that could have led
to further unnecessary invasive interventions, as well as cause the patient significant distress regarding
management and prognosis. However, high degree of suspicion and confirmation by cultures and
histopathological exam done through bronchoscopy and bronchial alveolar lavage eventually revealed
and confirmed the diagnosis of pulmonary actinomycosis caused by actinomyces oris. Treatment of
which was done successfully and resulted in significant improvement in the patient’s clinical condition
and CT results.
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Abstract
The implications of misdiagnosis can be drastic, especially when the correct diagnosis is treatable. Pulmonary actinomycosis is one of the complications of infection with actinomyces, an anaerobic gram-positive organism that is usually
found as a part of the normal ﬂora in the human body infection. It is a very rare disease and is frequently mistaken with
other diagnoses owing to its nonspeciﬁc presentation. In this report, we present a 67-year-old male with a mass like
lesion on a CT scan of his chest that was done due to progressively worsening productive cough, weight loss and fatigue.
These symptoms could have swayed any physician into the diagnosis of possible malignancy. A misdiagnosis that could
have led to further unnecessary invasive interventions, as well as cause the patient signiﬁcant distress regarding
management and prognosis. However, high degree of suspicion and conﬁrmation by cultures and histopathological
exam done through bronchoscopy and bronchial alveolar lavage eventually revealed and conﬁrmed the diagnosis of
pulmonary actinomycosis caused by actinomyces oris. Treatment of which was done successfully and resulted in signiﬁcant improvement in the patient's clinical condition and CT results.
Keywords: Pulmonary actinomycosis, Actinomyces

1. Introduction

A

ctinomycosis is a rare chronic disease caused
by Actinomyces species. An in-depth literature review revealed 94 cases mentioned in articles
between 1980 and 2010, and only a handful of case
reports around the world since then.1e4 It is an
anaerobic gram-positive bacteria that is typically
found in the mouth, digestive tract, and genitalia.5
Most infections with Actinomyces occur due to
inadequate oral hygiene and are usually found in
patients with chronic alcohol abuse; however, infections can also occur in immunosuppressed individuals with HIV. Often, patients present with
nonspeciﬁc symptoms of pulmonary actinomycosis–
typically with productive cough, fever, shortness of
breath and unintentional weight loss–and the diagnosis is initially confused with other pulmonary
etiologies, including tuberculosis and lung cancer.6

This case report discusses the challenges in diagnosing and differentiating pulmonary actinomycosis
from other lung pathologies including malignancy,
especially in a patient who ﬁts the medical picture,
but may or may not have the appropriate risk factors
as described above.

2. Case presentation
A 67-year-old male with a past medical history of
type 2 diabetes mellitus, hypertension, and hyperlipidemia presented with complaints of worsening
productive cough, night sweats, and weight loss. His
cough started about two months prior and was
productive with thick greenish sputum without
blood. He reported loss of appetite with an
approximate 20-pound weight loss in two months.
The patient also smoked about two packs of cigarettes a day for the past 50 years. Additionally, he
lived and worked on a cattle farm. Of note, he
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Fig. 1. CT scan of the chest showing mass like lesions in the bilateral
upper lobes of the lungs.

Fig. 3. Hematoxylin-eosin stain of sulfur granule of Actinomyces within
an abscess, low power.

revealed a distant history of a sore tooth about four
to ﬁve months prior to presentation for which he
was seen by his dentist. He was told that there was
no acute infectious process going on at the time;
however, he was still treated with amoxicillin with
resolution of his symptoms. Physical examination at
the time of this presentation revealed mild
wheezing noted in the right side of his chest but was
otherwise unremarkable. His vital signs were stable
including a maximum temperature of 37.1  C. There
was no evidence of active infection or inﬂammation
in the oral cavity or jaw. Labs revealed an elevated
white blood cell count at 17.0 with predominance of
neutrophils at 77.4%.
He was initially seen by his primary care physician and was treated for community-acquired
pneumonia. His symptoms never resolved, and he
was thereafter referred to pulmonology where a CT
scan of his chest was done, which revealed a right
upper lobe mass with adenopathy (Fig. 1). Due to
the concerning mass, a PET scan was done, which
demonstrated bronchograms in the right upper lobe
with opacity, and an upper lobe opacity on the left
side (Fig. 2). The patient underwent bronchoscopy

with bronchial washings, which revealed sulfur
granules suggestive of Actinomyces (Fig. 3). Histopathology of a specimen from the right upper lobe
revealed a mass of branching ﬁlamentous bacteria
with a neutrophilic inﬁltrate, consistent with Actinomyces (Fig. 4). After the diagnosis of Actinomyces
oris was conﬁrmed, the patient was treated with four
weeks of intravenous Penicillin G followed by a
prolonged course of oral Amoxicillin, leading to a
decrease in the size of the mass on repeat CT
thereafter.

Fig. 2. Upper lobe patchy airspace consolidations measuring up to
7.4 cm in diameter in the right apex on PET-CT scan.
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3. Discussion
Actinomycosis has been found to be an endogenous infection. The bacteria are usually found on
the mucosal surface and make their way into deep
tissues by means of disruption of the mucosal area
through trauma, surgical procedures, or foreign
bodies.7
Pulmonary actinomycosis is the third most common type of complication noted by this organism,
after cervicofacial and abdominopelvic locations.

Fig. 4. High power histopathological view of specimen obtained from the
right upper lobe of the lung. Hematoxylin-eosin stain shows a mass of
branching ﬁlamentous bacteria with a neutrophilic inﬁltrate.
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Pulmonary actinomycosis accounts for about 15% of
all actinomycosis cases.8 It is rarely seen in children
and is mostly seen in males at a ratio of 3:1.9
Although pulmonary actinomycosis can occur from
direct spread from local infections or hematogenous
spread, ingestion or aspiration of oral secretions is
regarded as the key source of infection.7 This is
especially true in patients with certain conditions,
including alcohol abuse, diabetes mellitus, and
periodontal disease.10
As seen in our patient, he did have a prior history
of tooth ache. However, nothing was conﬁrmed that
showed active infection in the tooth. Thus, although
the possibility that this may have been the source of
his infection cannot be excluded, the patient had no
other obvious risk factors that would link him to this
diagnosis. This may mean the need to expand on the
risk factors and settings in which development of
this disease is possible to broaden the scope and
prevent misdiagnosis. Patients with other prior
pulmonary diseases, including COPD and bronchiectasis, are also at an increased risk for pulmonary
actinomycosis. Although our patient did not have a
history of any of these conditions, he did have a
history of chronic tobacco abuse.
In the early stages of this disease, patients present
with consolidation and some associated pulmonary
nodules without pulmonary symptoms. As time
goes on, there is constitution of a peripheral mass
which is slow-growing and at this point is usually
confused with malignancy. Imaging studies are
generally not speciﬁc. CT scan of the chest may
reveal consolidation, lymph node enlargement,
atelectasis, cavitation, ground-glass opacities, and
pleural effusions with no speciﬁc location in the
lung.5 Chest CT done in our patient was consistent
with adenopathy and a mass in the right upper lobe
of the lung.
Prior studies have attempted to diagnose pulmonary actinomycosis from sputum culture, but these
have been shown to be possible colonization, thus
diagnosing pulmonary actinomycosis can be difﬁcult.5 Current guidelines suggest the gold standard
for diagnosing pulmonary actinomycosis is histological and microbiological cultures from biopsy.5
Biopsies may be done by VATS, CT-guided or
bronchoscopy with transbronchial biopsies and
bronchoalveolar lavage, which were done in our
patient. While PET scan might be helpful, it has
been shown that up to 25% of cases with patients
with pulmonary actinomycosis were mistaken for
malignancies, as was the case with our patient.7
Thus, it is crucial for physicians to have an inclusive
differential diagnosis list and utilize proper diagnostic modalities.
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The choice of treatment is usually penicillin, and
the length of treatment can vary depending on the
severity of the disease. There is typically a combination of intravenous penicillin with oral penicillin
analog depending on the clinical response of the
patient. Our patient was treated with intravenous
antibiotics (IV penicillin) and showed signiﬁcant
improvement in his symptoms during his hospital
stay. He was transitioned to oral amoxicillin-clavulanic acid upon discharge and repeat chest CT
about one month later demonstrated improvement
in the size of the mass. The patient was instructed to
follow up regularly for monitoring to continue oral
antibiotics until full resolution of the mass.

4. Conclusion
Pulmonary actinomycosis is a rare condition
requiring a high level of suspicion to diagnose due
to the likelihood of it being mistaken for other
pulmonary conditions. Since symptoms of this disease overlap with many other lung pathologies,
histopathological and microbiological examination
of biopsy samples are crucial to help correctly diagnose this condition. It is also important to note
how patients can undergo unnecessary invasive
medical test and exams in search of an accurate
diagnosis and treatment plan. Management includes long term antibiotic treatment once an accurate diagnosis has been made.
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